Sakai Leo, Kazbour Hana, Huang James
Loma Linda University Health, Loma Linda, CA, USA.
Jerry L. Pettis Memorial Veteran's Hospital, Loma Linda, CA, USA.
J Investig Med High Impact Case Rep. 2025 Jan-Dec;13:23247096251344727. doi: 10.1177/23247096251344727. Epub 2025 May 26.
Statin-induced immune-mediated necrotizing myopathy (IMNM) is a rare subtype of idiopathic inflammatory myopathy associated with statin exposure and characterized by positive anti-hydroxymethylglutaryl coenzyme A reductase antibodies. Here, we describe a case of a 66-year-old male who was admitted with the presumed diagnosis of rhabdomyolysis in the setting of chronic statin use but was later confirmed to have statin-induced IMNM after his symptoms were refractory to treatment. This case highlights the importance of having a high clinical suspicion for statin-induced IMNM when statin-associated muscle symptoms fail to resolve after the discontinuation of statins.
他汀类药物诱导的免疫介导性坏死性肌病(IMNM)是一种罕见的特发性炎性肌病亚型,与他汀类药物暴露有关,其特征是抗羟甲基戊二酰辅酶A还原酶抗体阳性。在此,我们描述了一例66岁男性患者,因长期使用他汀类药物被疑诊为横纹肌溶解症入院,但在症状对治疗无效后,后来被确诊为他汀类药物诱导的IMNM。该病例强调了在停用他汀类药物后他汀类药物相关肌肉症状仍未缓解时,对他汀类药物诱导的IMNM保持高度临床怀疑的重要性。